In patients with T1D and obesity, combination therapy with insulin and semaglutide has been shown to improve HbA1c and reduce body weight without increasing the risk of hypoglycemia or diabetic ketoacidosis [82, 83]
In summary: two critical reviews of GLP/NLA suggest the framework is not evidence-based
It also reduces the risk of overlapping or confusing side effects, like nausea, constipation, fatigue, or hair thinning, symptoms common to both thyroid imbalance and GLP-1 medications
This guide builds a complete sublingual tirzepatide dosage chart from the ground up
If you cant get stress under control on your own, consider seeing a therapist or other mental health professional
(PubMed) Gould JF, Smithers LG, Makrides M